Back to Search
Start Over
Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approval.
- Source :
-
Leukemia Research . Jan2022, Vol. 112, pN.PAG-N.PAG. 1p. - Publication Year :
- 2022
- Subjects :
- *SECONDARY primary cancer
*RUXOLITINIB
*MYELOFIBROSIS
Subjects
Details
- Language :
- English
- ISSN :
- 01452126
- Volume :
- 112
- Database :
- Academic Search Index
- Journal :
- Leukemia Research
- Publication Type :
- Academic Journal
- Accession number :
- 154696821
- Full Text :
- https://doi.org/10.1016/j.leukres.2021.106770